Current View on Vessel Wall Lesion in Atherosclerosis and Arterial Hypertension

I.M. Fushtey, B.M. Goldovsky, V.О. Mochonyi, Ye.V. Sid

Abstract


Hypertension and atherosclerosis are the leading causes of cardiovascular morbidity and mortality in Ukraine. The damage of the blood vessels in these diseases has a number of common and different mechanisms. In cases of both essential hypertension and atherosclerosis there is a morphological rearrangement of the vessel wall and increased activity of cardiotropic markers of inflammatory response. The research study of these mechanisms allows not only improve the prediction of the course of essential hypertension and atherosclerosis, but to develop new approaches of treatment of such patients, which will prevent further progressing of vascular changes.


Keywords


hypertension; atherosclerosis; inflammation; cytokines

References


Anychkov H.H. Novыe dannыe po voprosu o patolohyy y эtyolohyy ateroskleroza (arteryoskleroza). / H.H. Anychkov // Russkyy vrach. — 1915. — #8 — S. 184-186; #9. — S. 207-211.

Aronov D.M. Nekotorыe aspektы patoheneza ateroskleroza / D.M. Aronov, V.P. Lupanov // Ateroskleroz y dyslypydemyy. — 2011. — # 1. — S. 48-56.

Arterial'na hipertenziya. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazakh / Asotsiatsiya kardiolohiv Ukrayiny. — K., 2012. — 139s.

Vashchenko Y.S. Vklad N.N. Anychkova v sozdanye kholesterynovoy modely ateroskleroza / Vashchenko Y.S., Chebotareva E.H. // Byulleten' medytsynskykh ynternet-konferentsyy. «Nauka y ynnovatsyy». — 2012. — T. 2, № 11. — S. 844.

Vel'kov V.V. S-reaktyvnыy belok v laboratornoy dyahnostyke ostrыkh vospalenyy y v otsenke ryskov sosudystыkh patolohyy / V.V. Vel'kov // Klynyko-laboratornыy konsylyum. — 2008 — № 2 (21). — S. 37-48.

Morfolohycheskaya struktura aterosklerotycheskykh blyashek synusa vnutrenney sonnoy arteryy y ykh ul'trazvukovaya kharakterystyka / T.S. Hulevskaya, V.A. Morhunov, P.L. Anufryev [y dr.] // Ul'trazvukovaya y funktsyonal'naya dyahnostyka. — 2004. — № 4. — S. 68-77.

Svishchenko Ye.P Vyyavlennya ta likuvannya arterial'noyi hipertenziyi v Ukrayini: real'nist' ta perspektyvy / Ye.P. Svishchenko // Ukrayins'kyy kardiolohichnyy zhurnal. — 2010. — Dodatok 1. — S. 13-15.

Svishchenko Ye.P. Znachennya netradytsiynykh faktoriv sertsevo–sudynnoho ryzyku dlya rozvytku i prohresuvannya hipertonichnoyi khvoroby / Ye.P. Svishchenko, L.A. Mishchenko // Ukr. terapevt. zhurn. — 2011. — № 9. — S. 16-21.

Alexander R.W. Hypertension and the pathogenesis of atherosclerosis oxidative stress and the mediation of arterial inflammatory response: a new perspective // Hypertension. — 1995. — 25 (2). — Р. 155-161. http://dx.doi.org/10.1161/01.hyp.25.2.155

Araujo M., Wilcox C.S. Oxidative stress in hypertension: role of the kidney // Antioxidants & redox signaling. — 2014. — 20 (1). — Р. 74-101. http://dx.doi.org/10.1089/ars.2013.5259

Chrysohoou C., Pitsavos C., Panagiotakos D.B., Skoumas J., Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease* The ATTICA Study // American journal of hypertension. — 2004. — 17 (7). — Р. 568-573. http://dx.doi.org/10.1016/j.amjhyper.2004.03.675

Nagano M., Nakamura M., Sato K., Tanaka F., Segawa T., Hiramori K. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population // Atherosclerosis. — 2005. — 180 (1). — Р. 189-195. http://dx.doi.org/10.1016/j.atherosclerosis.2004.11.019

Buranakitjaroen P. Hypertension audit in clinical practice based in Thailand (HABIT) // Journal of the Medical Association of Thailand = Chotmaihet thangphaet. — 2011. — 94. — S57-65.

Wilson P.W., Pencina M., Jacques P., Selhub J., D'Agostino R., O'Donnell C.J. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study // Circulation: Cardiovascular Quality and Outcomes. — 2008. — 1 (2). — Р. 92-97. http://dx.doi.org/10.1161/circoutcomes.108.831198

Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., Ridker P.M. C-reactive protein and the risk of developing hypertension // JAMA. — 2003. — 290 (22). — Р. 2945-2951. http://dx.doi.org/10.1001/jama.290.22.2945

Dal Palu C. Hypertension and atherosclerosis // Journal of human hypertension. — 1996. — 10. — S89-92.

Stumpf C., John S., Jukic J., Yilmaz A., Raaz D., Schmieder R.E., Garlichs C.D. Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension // Journal of hypertension. — 2005. — 23 (5). — Р. 995-1000. http://dx.doi.org/10.1097/01.hjh.0000166840.63312.12

Catapano A. L., Reiner Ž., De Backer G., Graham I., Taskinen M.R., Wiklund O., Windecker S. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) // Atherosclerosis. — 2011. — 217. — Р. 1-44. http://dx.doi.org/10.1016/j.atherosclerosis.2011.06.012

Schillaci G., Pirro M., Gemelli F., Pasqualini L., Vaudo G., Marchesi S., Mannarino E. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures // Journal of hypertension. — 2003. — 21 (10). — Р. 1841-1846. http://dx.doi.org/10.1097/00004872-200310000-00010

Yerramasu A., Dey D., Venuraju S., Anand D. V., Atwal S., Corder R., Lahiri A. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis // Atherosclerosis. — 2012. — 220 (1). — Р. 223-230. http://dx.doi.org/10.1016/j.atherosclerosis.2011.09.041

Bautista L.E., Vera L.M., Arenas I.A., Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension // Journal of human hypertension. — 2005. — 19 (2). — Р. 149-154. http://dx.doi.org/10.1038/sj.jhh.1001785

Chamarthi B., Williams G. H., Ricchiuti V., Srikumar N., Hopkins P. N., Luther J.M., Thomas A. Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the rennin-angiotensin system in humans // American journal of hypertension. — 2011. — 24 (10). — Р. 1143-1148. http://dx.doi.org/10.1038/ajh.2011.113

Lassègue B., San Martín A., Griendling K.K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system // Circulation. — research, 110 (10). — Р. 1364-1390. http://dx.doi.org/10.1161/circresaha.111.243972

Niskanen L., Laaksonen D.E., Nyyssönen K., Punnonen K., Valkonen V.P., Fuentes R., Salonen, J.T. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. — 2004. — 44 (6). — Р. 859-865. http://dx.doi.org/10.1161/01.hyp.0000146691.51307.84

Mancia G., Facchetti R., Parati G., & Zanchetti, A. Visit-to-visit blood pressure variability, carotid atherosclerosis and cardiovascular events in the European Lacidipine Study on Atherosclerosis // Circulation. — 2012. — CIRCULATIONAHA-112. http://dx.doi.org/10.1161/circulationaha.112.107565

Willerson J. T., & Ridker P. M. (). Inflammation as a cardiovascular risk factor // Circulation. — 2004. — 109 (21, suppl. 1), II-2. ttp://dx.doi.org/10.1161/01.cir.0000129535.04194.38




DOI: https://doi.org/10.22141/2224-0586.6.69.2015.78641

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru